Biotech and pharmaceutical investors, among others, need to watch out for the way firms treat the cost of developing new products, as this can have a big impact on a firm’s results. In his fifth video in the ‘cooking the books’ series, Tim Bennett explains how.
More from this series
• How investors can be fooled by brands
• How investors can be fooled by long-term assets
• How investors can be fooled by long-term contracts
• How you can be fooled by provisions